Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 9 | 2020 | 1173 | 0.970 |
Why?
|
| Neuropilin-2 | 5 | 2020 | 19 | 0.890 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2020 | 300 | 0.810 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 114 | 0.600 |
Why?
|
| Semaphorins | 3 | 2007 | 7 | 0.550 |
Why?
|
| Neovascularization, Pathologic | 4 | 2019 | 183 | 0.530 |
Why?
|
| Membrane Proteins | 5 | 2019 | 617 | 0.520 |
Why?
|
| Melanoma | 1 | 2018 | 335 | 0.480 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2016 | 135 | 0.470 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 375 | 0.460 |
Why?
|
| Cell Adhesion | 3 | 2005 | 324 | 0.440 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 126 | 0.430 |
Why?
|
| Cell Movement | 6 | 2020 | 630 | 0.380 |
Why?
|
| Nerve Tissue Proteins | 4 | 2007 | 290 | 0.350 |
Why?
|
| Angiopoietin-2 | 1 | 2009 | 5 | 0.330 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 214 | 0.320 |
Why?
|
| Mice, Nude | 4 | 2019 | 294 | 0.310 |
Why?
|
| Melanoma, Experimental | 1 | 2009 | 95 | 0.310 |
Why?
|
| Homeodomain Proteins | 3 | 2016 | 157 | 0.300 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2011 | 219 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 332 | 0.260 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 1851 | 0.260 |
Why?
|
| Cadherins | 2 | 2010 | 93 | 0.260 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2020 | 331 | 0.260 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 1536 | 0.250 |
Why?
|
| Signal Transduction | 8 | 2017 | 2689 | 0.250 |
Why?
|
| Mice | 9 | 2019 | 8474 | 0.240 |
Why?
|
| Transcription Factors | 3 | 2016 | 753 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 756 | 0.230 |
Why?
|
| Animals | 14 | 2019 | 20881 | 0.230 |
Why?
|
| Neovascularization, Physiologic | 2 | 2017 | 164 | 0.220 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 25 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 4 | 2019 | 852 | 0.220 |
Why?
|
| Lymphokines | 1 | 2003 | 49 | 0.220 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 146 | 0.200 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1174 | 0.200 |
Why?
|
| Up-Regulation | 3 | 2013 | 682 | 0.180 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 434 | 0.180 |
Why?
|
| Acrylamides | 1 | 2020 | 12 | 0.180 |
Why?
|
| Aniline Compounds | 1 | 2020 | 52 | 0.180 |
Why?
|
| Hemangiosarcoma | 1 | 2019 | 23 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 41 | 0.170 |
Why?
|
| Transfection | 3 | 2018 | 782 | 0.170 |
Why?
|
| Thioredoxins | 1 | 2019 | 26 | 0.170 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 151 | 0.160 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 53 | 0.160 |
Why?
|
| Heterografts | 1 | 2018 | 70 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2018 | 447 | 0.150 |
Why?
|
| Cell Proliferation | 5 | 2020 | 1174 | 0.150 |
Why?
|
| Frizzled Receptors | 1 | 2017 | 8 | 0.150 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 40 | 0.150 |
Why?
|
| Interferon-gamma | 1 | 2018 | 241 | 0.140 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 1033 | 0.130 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 597 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1070 | 0.120 |
Why?
|
| Neuropilin-1 | 2 | 2005 | 4 | 0.120 |
Why?
|
| ErbB Receptors | 1 | 2016 | 239 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 384 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1034 | 0.110 |
Why?
|
| Neoplasms | 1 | 2005 | 1667 | 0.110 |
Why?
|
| Female | 9 | 2019 | 38074 | 0.110 |
Why?
|
| Lung | 2 | 2010 | 849 | 0.110 |
Why?
|
| Apoptosis | 1 | 2019 | 1641 | 0.100 |
Why?
|
| Endothelial Cells | 2 | 2017 | 384 | 0.100 |
Why?
|
| Humans | 15 | 2020 | 68618 | 0.100 |
Why?
|
| Cell Membrane | 2 | 2005 | 525 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 235 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 2550 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2017 | 954 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 2 | 2016 | 196 | 0.090 |
Why?
|
| Microcirculation | 1 | 2009 | 77 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2016 | 1664 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 710 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 2791 | 0.080 |
Why?
|
| Cell Division | 1 | 2009 | 541 | 0.080 |
Why?
|
| Pericytes | 1 | 2009 | 81 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2007 | 30 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 800 | 0.070 |
Why?
|
| DNA Primers | 2 | 2005 | 302 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2007 | 230 | 0.070 |
Why?
|
| Carcinogens | 1 | 2005 | 86 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 61 | 0.060 |
Why?
|
| beta Catenin | 1 | 2005 | 73 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2009 | 1692 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 108 | 0.060 |
Why?
|
| Transplantation, Heterologous | 2 | 2017 | 122 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 304 | 0.060 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 2 | 2016 | 22 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2005 | 237 | 0.060 |
Why?
|
| Pseudopodia | 1 | 2003 | 16 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 331 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2003 | 23 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 37 | 0.050 |
Why?
|
| COS Cells | 1 | 2003 | 155 | 0.050 |
Why?
|
| Cricetinae | 1 | 2003 | 262 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 337 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 166 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 492 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2020 | 1200 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2020 | 57 | 0.040 |
Why?
|
| A549 Cells | 1 | 2020 | 50 | 0.040 |
Why?
|
| Gene Expression | 1 | 2003 | 770 | 0.040 |
Why?
|
| Kidney | 1 | 2005 | 945 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 97 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2011 | 183 | 0.040 |
Why?
|
| Protein Binding | 2 | 2017 | 1027 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2005 | 2673 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 108 | 0.040 |
Why?
|
| gp100 Melanoma Antigen | 1 | 2019 | 16 | 0.040 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2019 | 18 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1293 | 0.040 |
Why?
|
| L-Selectin | 1 | 2019 | 28 | 0.040 |
Why?
|
| Male | 2 | 2018 | 37321 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 369 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2020 | 791 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 135 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2011 | 248 | 0.040 |
Why?
|
| Structural Homology, Protein | 1 | 2017 | 16 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 213 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2017 | 42 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 742 | 0.040 |
Why?
|
| Antioxidants | 1 | 2019 | 304 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2017 | 231 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 499 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 507 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 947 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 266 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 150 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 147 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 209 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 714 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 718 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 1083 | 0.030 |
Why?
|
| Mitochondria | 1 | 2019 | 643 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 929 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 1752 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 1038 | 0.030 |
Why?
|
| Netrin Receptors | 1 | 2011 | 3 | 0.020 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2010 | 5 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2011 | 45 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 92 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2010 | 50 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 1213 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2011 | 102 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 238 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 326 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 562 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 4848 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 71 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 86 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2007 | 25 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2007 | 291 | 0.020 |
Why?
|
| Rats, Nude | 1 | 2005 | 5 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2005 | 15 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 78 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 160 | 0.020 |
Why?
|
| Integrins | 1 | 2005 | 115 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 261 | 0.010 |
Why?
|
| Plasmids | 1 | 2005 | 258 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2005 | 306 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 901 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2005 | 493 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 14862 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 21147 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 21403 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 5300 | 0.010 |
Why?
|